Nuvo Pharmaceuticals Inc
TSX:MRV
Nuvo Pharmaceuticals Inc
Revenue
Nuvo Pharmaceuticals Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
Revenue
CA$72.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
31%
|
CAGR 10-Years
11%
|
|
Bausch Health Companies Inc
TSX:BHC
|
Revenue
$8.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
Canopy Growth Corp
TSX:WEED
|
Revenue
CA$298.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Cronos Group Inc
TSX:CRON
|
Revenue
$87.2m
|
CAGR 3-Years
23%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Revenue
$2.3B
|
CAGR 3-Years
71%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
T
|
Terrascend Corp
CNSX:TER
|
Revenue
$247.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Nuvo Pharmaceuticals Inc's Revenue?
Revenue
72.4m
CAD
Based on the financial report for Sep 30, 2022, Nuvo Pharmaceuticals Inc's Revenue amounts to 72.4m CAD.
What is Nuvo Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
11%
Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for Nuvo Pharmaceuticals Inc have been 10% over the past three years , 31% over the past five years , and 11% over the past ten years .